A comprehensive view of F. Hoffmann-La Roche Ltd. (Roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
F. Hoffmann-La Roche Ltd. Champions Clinical Trials, Innovates in Ophthalmology, and Advocates for Personalized Medicine at Impact CEE
Published:
May 20, 2024
by Industry Intelligence Inc.
|
INTERNATIONAL PATENT: GENENTECH, INC., HOFFMANN-LA ROCHE INC., F. HOFFMANN-LA ROCHE AG FILES APPLICATION FOR "COMPOSITIONS AND METHODS OF TREATING CHILDHOOD ONSET IDIOPATHIC NEPHROTIC SYNDROME"
Published:
May 20, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: GENENTECH, INC., F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "ENZYMATIC ASYMMETRIC SYNTHESES OF N-ALKYL AMINO ACIDS"
Published:
May 20, 2024
by U.S. Fed News
|
F Hoffmann-La Roche AG Files Patent Application for Method and System for Automated Activity Recommendation in Diabetes Treatment Plans
Published:
May 20, 2024
by Indian Patents News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "ANTIBODIES BINDING TO HLA-A*02/FOXP3"
Published:
May 19, 2024
by U.S. Fed News
|
Ask us about our Government & Public Policy market view